Literature DB >> 21402966

Withdrawing medication: managing medical comorbidities near the end of life.

Christopher P O'Brien1.   

Abstract

Mesh：

Year:  2011        PMID： 21402966      PMCID： PMC3056678     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN： 0008-350X            Impact factor:   3.275


× No keyword cloud information.
  12 in total

1.  Finding the evidence for thromboprophylaxis in palliative care: first let us agree on the question.

Authors:  Simon Noble; Miriam Johnson
Journal:  Palliat Med       Date:  2010-06       Impact factor: 4.762

Review 2.  Managing comorbidities in patients at the end of life.

Authors:  James Stevenson; Amy P Abernethy; Cathy Miller; David C Currow
Journal:  BMJ       Date:  2004-10-16

3.  Reconsidering medication appropriateness for patients late in life.

Authors:  Holly M Holmes; Déon Cox Hayley; G Caleb Alexander; Greg A Sachs
Journal:  Arch Intern Med       Date:  2006-03-27

Review 4.  ABC of palliative care. The last 48 hours.

Authors:  J Adam
Journal:  BMJ       Date:  1997-12-13

5.  Dying patients in the intensive care unit: forgoing treatment, maintaining care.

Authors:  K Faber-Langendoen; P N Lanken
Journal:  Ann Intern Med       Date:  2000-12-05       Impact factor: 25.391

6.  Venous thromboembolism in patients with advanced cancer under palliative care: additional risk factors, primary/secondary prophylaxis and complications observed under normal clinical practice.

Authors:  M J Soto-Cárdenas; G Pelayo-García; A Rodríguez-Camacho; E Segura-Fernández; A Mogollo-Galván; J A Giron-Gonzalez
Journal:  Palliat Med       Date:  2008-10-24       Impact factor: 4.762

Review 7.  Can I stop the warfarin? A review of the risks and benefits of discontinuing anticoagulation.

Authors:  Jeffrey L Spiess
Journal:  J Palliat Med       Date:  2009-01       Impact factor: 2.947

Review 8.  Withdrawal of cardiac medications and devices.

Authors:  Debra Lynn-McHale Wiegand; Peggy G Kalowes
Journal:  AACN Adv Crit Care       Date:  2007 Oct-Dec

9.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

Authors: 
Journal:  Lancet       Date:  1998-09-12       Impact factor: 79.321

10.  Number needed to treat with rosuvastatin to prevent first cardiovascular events and death among men and women with low low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein: justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin (JUPITER).

Authors:  Paul M Ridker; Jean G MacFadyen; Francisco A H Fonseca; Jacques Genest; Antonio M Gotto; John J P Kastelein; Wolfgang Koenig; Peter Libby; Alberto J Lorenzatti; Børge G Nordestgaard; James Shepherd; James T Willerson; Robert J Glynn
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2009-09-22
View more
  3 in total

Review 1.  Deprescribing medicines in older people living with multimorbidity and polypharmacy: the TAILOR evidence synthesis.

Authors:  Joanne Reeve; Michelle Maden; Ruaraidh Hill; Amadea Turk; Kamal Mahtani; Geoff Wong; Dan Lasserson; Janet Krska; Dee Mangin; Richard Byng; Emma Wallace; Ed Ranson
Journal:  Health Technol Assess       Date:  2022-07       Impact factor: 4.106

2.  Appropriateness of medications prescribed to elderly patients with advanced heart failure and limited life expectancy who died during hospitalization.

Authors:  Montserrat Barceló; Olga Torres; Domingo Ruiz; Jordi Casademont
Journal:  Drugs Aging       Date:  2014-07       Impact factor: 3.923

3.  Does special education in palliative medicine make a difference in end-of-life decision-making?

Authors:  Reetta P Piili; Juho T Lehto; Tiina Luukkaala; Heikki Hinkka; Pirkko-Liisa I Kellokumpu-Lehtinen
Journal:  BMC Palliat Care       Date:  2018-07-18       Impact factor: 3.234
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.